Publications

Detailed Information

HIF-2 alpha Enhances beta-Catenin/TCF-Driven Transcription by Interacting with beta-Catenin

DC Field Value Language
dc.contributor.authorChoi, Hyunsung-
dc.contributor.authorChun, Yang-Sook-
dc.contributor.authorPark, Jong-Wan-
dc.contributor.authorKim, Tae-You-
dc.date.accessioned2012-05-22T02:15:49Z-
dc.date.available2012-05-22T02:15:49Z-
dc.date.issued2010-12-15-
dc.identifier.citationCANCER RESEARCH; Vol.70 24; 10101-10111ko_KR
dc.identifier.issn0008-5472-
dc.identifier.urihttps://hdl.handle.net/10371/76206-
dc.description.abstractThe tumor-promoting factors beta-catenin and hypoxia-inducible factor (HIF) are often found to be coactivated in rapidly growing tumors. Recently, it was shown that HIF-1 alpha negatively regulates Wnt/beta-catenin signaling by sequestering beta-catenin from beta-catenin/T-cell factor (TCF). However, no investigation has been undertaken on the involvement of HIF-2 alpha in beta-catenin regulation. In this study, it was found that, like HIF-1 alpha, HIF-2 alpha interacts with beta-catenin, but at a different site. Furthermore, HIF-2 alpha was found to assemble with beta-catenin/TCF and facilitate gene transcription. Mutational analyses revealed that transactivation domains of HIF-2 alpha promote p300 coactivator recruitment by beta-catenin. Furthermore, HIF-2 alpha and beta-catenin were found to associate in the nuclei of 786-0 renal cell carcinoma cells, and HIF-2 alpha was found to be required for beta-catenin activation in these cells and for their proliferation. These results suggest that this interaction contributes to the unrestrained growth of tumor cells containing coactivated HIF-2 alpha and beta-catenin. Interestingly, these actions of HIF-2 alpha oppose those of HIF-1 alpha on beta-catenin and cell growth, and this suggests that HIF-1 alpha/HIF-2 alpha balance may importantly determine cell growth when hypoxia and Wnt stimulation coexist. Cancer Res; 70(24); 10101-11. (C) 2010 AACR.ko_KR
dc.language.isoenko_KR
dc.publisherAMER ASSOC CANCER RESEARCHko_KR
dc.titleHIF-2 alpha Enhances beta-Catenin/TCF-Driven Transcription by Interacting with beta-Cateninko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor최현성-
dc.contributor.AlternativeAuthor김태유-
dc.contributor.AlternativeAuthor박종완-
dc.contributor.AlternativeAuthor전양숙-
dc.identifier.doi10.1158/0008-5472.CAN-10-0505-
dc.citation.journaltitleCANCER RESEARCH-
dc.description.citedreferenceRuas JL, 2010, J BIOL CHEM, V285, P2601, DOI 10.1074/jbc.M109.021824-
dc.description.citedreferenceMacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016-
dc.description.citedreferenceQing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001-
dc.description.citedreferenceChitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781-
dc.description.citedreferenceLim JH, 2008, CANCER RES, V68, P5177, DOI 10.1158/0008-5472.CAN-07-6234-
dc.description.citedreferenceHu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419-
dc.description.citedreferenceXu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771-
dc.description.citedreferenceLofstedt T, 2007, CELL CYCLE, V6, P919-
dc.description.citedreferenceGordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006-
dc.description.citedreferenceKaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534-
dc.description.citedreferencePolakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007-
dc.description.citedreferenceHolmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026-
dc.description.citedreferencevan de Wetering M, 2002, CELL, V111, P241-
dc.description.citedreferenceLidgren A, 2005, CLIN CANCER RES, V11, P1129-
dc.description.citedreferenceMaher ER, 2004, CURR MOL MED, V4, P833-
dc.description.citedreferenceWarnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje-
dc.description.citedreferenceKoshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196-
dc.description.citedreferenceSchofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366-
dc.description.citedreferenceLevy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004-
dc.description.citedreferenceMaynard MA, 2004, AM J NEPHROL, V24, P1, DOI 10.1159/000075346-
dc.description.citedreferenceKondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083-
dc.description.citedreferenceMandriota SJ, 2002, CANCER CELL, V1, P459-
dc.description.citedreferenceFreedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899-
dc.description.citedreferenceLando D, 2002, SCIENCE, V295, P858-
dc.description.citedreferenceHarris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704-
dc.description.citedreferenceChun YS, 2001, J CELL SCI, V114, P4051-
dc.description.citedreferenceWiesener MS, 1998, BLOOD, V92, P2260-
dc.description.citedreferenceHe TC, 1998, SCIENCE, V281, P1509-
dc.description.citedreferenceAn WG, 1998, NATURE, V392, P405-
dc.description.citedreferenceWANG GL, 1995, J BIOL CHEM, V270, P1230-
dc.description.tc3-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share